Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOPPekka Peroja, Outi Kuittinen, Jenni Peltonen et al.|Scientific Reports|2018Cited by 31
Rare missense mutations in <i>RECQL</i> and <i>POLG</i> associate with inherited predisposition to breast cancerAnna Tervasmäki, Katri Pylkäs, Tuomo Mantere et al.|International Journal of Cancer|2018Cited by 19
The Role of Redox‐Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant ChemotherapyNelli Roininen, Peeter Karihtala|Oxidative Medicine and Cellular Longevity|2017Cited by 6